762 related articles for article (PubMed ID: 26015857)
1. Recent advances in the diagnosis and treatment of acute myocardial infarction.
Reddy K; Khaliq A; Henning RJ
World J Cardiol; 2015 May; 7(5):243-76. PubMed ID: 26015857
[TBL] [Abstract][Full Text] [Related]
2. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
Traverse JH; Henry TD; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Forder JR; Byrne BJ; Hatzopoulos AK; Penn MS; Perin EC; Baran KW; Chambers J; Lambert C; Raveendran G; Simon DI; Vaughan DE; Simpson LM; Gee AP; Taylor DA; Cogle CR; Thomas JD; Silva GV; Jorgenson BC; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Smith DX; Baraniuk S; Piller LB; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
JAMA; 2011 Nov; 306(19):2110-9. PubMed ID: 22084195
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
Tricoci P; Newby LK; Clare RM; Leonardi S; Gibson CM; Giugliano RP; Armstrong PW; Van de Werf F; Montalescot G; Moliterno DJ; Held C; Aylward PE; Wallentin L; Harrington RA; Braunwald E; Mahaffey KW; White HD
JACC Cardiovasc Interv; 2018 May; 11(9):856-864. PubMed ID: 29747915
[TBL] [Abstract][Full Text] [Related]
4. Contemporary NSTEMI management: the role of the hospitalist.
Pollack CV; Amin A; Wang T; Deitelzweig S; Cohen M; Slattery D; Fanikos J; DiLascia C; Tuder R; Kaatz S
Hosp Pract (1995); 2020 Feb; 48(1):1-11. PubMed ID: 31815570
[TBL] [Abstract][Full Text] [Related]
5. Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study.
Montalescot G; Collet JP; Ecollan P; Bolognese L; Ten Berg J; Dudek D; Hamm C; Widimsky P; Tanguay JF; Goldstein P; Brown E; Miller DL; LeNarz L; Vicaut E;
J Am Coll Cardiol; 2014 Dec; 64(24):2563-2571. PubMed ID: 25524333
[TBL] [Abstract][Full Text] [Related]
6. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
Traverse JH; Henry TD; Moye' LA
Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
[TBL] [Abstract][Full Text] [Related]
7. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size.
Nijveldt R; van der Vleuten PA; Hirsch A; Beek AM; Tio RA; Tijssen JG; Piek JJ; van Rossum AC; Zijlstra F
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1187-94. PubMed ID: 19833308
[TBL] [Abstract][Full Text] [Related]
8. The new definition of myocardial infarction: analysis of the ESC/ACC Consensus Document and reflections on its applicability to the Italian Health System.
Galvani M; Panteghini M; Ottani F; Cappelletti P; Chiarella F; Chiariello M; Crea F; Dolci A; Golino P; Greco C; Nicolosi GL; Plebani M; Tubaro M; Zaninotto M;
Ital Heart J; 2002 Sep; 3(9):543-57. PubMed ID: 12407856
[TBL] [Abstract][Full Text] [Related]
9. [New definition of myocardial infarction: analysis of the consensus document ESC/ACC and thoughts about applicability to the Italian health situation].
Galvani M; Panteghini M; Ottani F; Cappelletti P; Chiarella F; Chiariello M; Crea F; Dolci A; Golino P; Greco C; Nicolosi GL; Plebani M; Tubaro M; Zaninotto M;
Ital Heart J Suppl; 2002 Sep; 3(9):955-70. PubMed ID: 12407866
[TBL] [Abstract][Full Text] [Related]
10. State-of-the-art diagnosis of myocardial infarction.
Vafaie M
Diagnosis (Berl); 2016 Dec; 3(4):137-142. PubMed ID: 29536900
[TBL] [Abstract][Full Text] [Related]
11. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
[TBL] [Abstract][Full Text] [Related]
12. [The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
Galli M; Maggioni AP; Vassanelli C; Tavazzi L
Ital Heart J Suppl; 2000 Feb; 1(2):202-11. PubMed ID: 10731377
[TBL] [Abstract][Full Text] [Related]
13. High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.
Kozinski M; Krintus M; Kubica J; Sypniewska G
Crit Rev Clin Lab Sci; 2017 May; 54(3):143-172. PubMed ID: 28457177
[TBL] [Abstract][Full Text] [Related]
14. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
Silva MA; Donovan JL; Gandhi PJ; Volturo GA
Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468
[TBL] [Abstract][Full Text] [Related]
15. Cardiac troponin after percutaneous coronary intervention and 1-year mortality in non-ST-segment elevation acute coronary syndrome using systematic evaluation of biomarker trends.
Tricoci P; Leonardi S; White J; White HD; Armstrong PW; Montalescot G; Giugliano RP; Gibson CM; Van de Werf F; Califf RM; Harrington RA; Braunwald E; Mahaffey KW; Newby LK
J Am Coll Cardiol; 2013 Jul; 62(3):242-251. PubMed ID: 23684676
[TBL] [Abstract][Full Text] [Related]
16. Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.
De Luca G; Savonitto S; van't Hof AW; Suryapranata H
Drugs; 2015 Jul; 75(11):1229-53. PubMed ID: 26177890
[TBL] [Abstract][Full Text] [Related]
17. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
[TBL] [Abstract][Full Text] [Related]
18. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
[TBL] [Abstract][Full Text] [Related]
19. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
[TBL] [Abstract][Full Text] [Related]
20. The reduction of infarct size--forty years of research.
Ferreira R
Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
